Nanocopoeia is a drug delivery company developing a nanotechnology-enabled portfolio of therapeutic products.
ElectroNanospray™ creates new proprietary products by enhancing the value and performance of off-patent, already proven drugs; taking advantage of the efficient 505(b)(2) regulatory pathway for minimizing the time to market.
ElectroNanospray™ enables novel nanoformulations of those drugs optimized for delivery to and through the skin.
